Each platform offers distinct advantages depending on antigen properties, timeline, and downstream application.<\/p>\n\n
At AbTriva, we provide flexible monoclonal antibody development solutions tailored to different research needs:<\/p>\n
- \n
- End-to-end antibody development or modular services<\/li>\n
- Multiple discovery platforms to match target complexity<\/li>\n
- Support for applications such as WB, ELISA, IHC, and flow cytometry<\/li>\n
- Scalable production from early discovery to preclinical research<\/li>\n <\/ul>\n\n
In addition to custom services, we maintain a growing portfolio of in-stock monoclonal antibodies covering a wide range of targets for immediate use.<\/p>\n\n
Production Platforms<\/h2>\n
We offer multiple monoclonal antibody discovery platforms, allowing researchers to select the most appropriate approach based on target type, application, and timeline.<\/p>\n\n
\n \n
\n Platform<\/b><\/th>\n Best For<\/b><\/th>\n Key Advantages<\/b><\/th>\n <\/tr>\n <\/thead>\n \n \n Hybridoma Development Platform<\/td>\n Standard immunogenic proteins<\/td>\n Well-established method, stable monoclonal cell lines, cost-effective<\/td>\n <\/tr>\n \n Phage Display Platform<\/td>\n Toxic, non-immunogenic, or highly conserved targets<\/td>\n In vitro selection, large library diversity, no need for animal immunization<\/td>\n <\/tr>\n \n FACS Single B Cell Sorting Platform<\/td>\n Rapid identification of antigen-specific B cells<\/td>\n High-throughput sorting of memory B cells, efficient early-stage screening<\/td>\n <\/tr>\n \n Beacon Single B Cell Platform<\/td>\n Functional antibody discovery and characterization<\/td>\n Microfluidics-based system enabling real-time analysis of antibody secretion, binding, and functional activity<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n\n Platform selection matters.<\/b>
FACS-based methods rely on flow cytometry to isolate antigen-binding B cells, while Beacon technology uses microfluidics to screen antibody-secreting cells at the single-cell level with functional readouts. In many projects, combining platforms can improve discovery efficiency and reduce bias.<\/p>\n\nPopular Monoclonal Antibody Development Services<\/h2>\n
We offer both end-to-end solutions and modular services depending on your project requirements.<\/p>\n\n
Full-Service Antibody Development<\/h3>\n
- \n
- Antigen design and preparation (peptide or recombinant protein)<\/li>\n
- Animal immunization and immune response monitoring<\/li>\n
- Hybridoma generation or single B-cell isolation<\/li>\n
- Screening and clone selection<\/li>\n
- Antibody expression and purification<\/li>\n
- Basic validation and QC<\/li>\n <\/ul>\n\n
Standalone Services<\/h3>\n
- \n
- Antigen design and synthesis<\/li>\n
- Immunization services<\/li>\n
- Hybridoma screening and subcloning<\/li>\n
- Recombinant antibody expression (CHO, HEK293)<\/li>\n
- Antibody purification<\/li>\n <\/ul>\n\n
Advanced Engineering Services<\/h3>\n
- \n
- Antibody humanization<\/li>\n
- Affinity maturation<\/li>\n
- Epitope mapping<\/li>\n
- Isotype switching and subclass engineering<\/li>\n <\/ul>\n\n
These services can be combined or customized depending on your workflow and experimental goals.<\/p>\n\n
Applications & Use Cases<\/h2>\n
Our monoclonal antibodies can be developed to support a wide range of research and assay applications, including:<\/p>\n
- \n
- Western blot (WB)<\/li>\n
- Enzyme-linked immunosorbent assay (ELISA)<\/li>\n
- Immunohistochemistry (IHC)<\/li>\n
- Immunocytochemistry (ICC)<\/li>\n
- Flow cytometry<\/li>\n
- Immunoprecipitation (IP)<\/li>\n
- Functional blocking or neutralization assays<\/li>\n <\/ul>\n\n
Application-specific validation is not performed by default for all assays.<\/p>\n
Validation strategies are defined based on your project requirements, target characteristics, and intended downstream use. Relevant assays can be incorporated into the workflow upon request.<\/p>\n\n
Overview of the Workflow<\/h2>\n
\n\n <\/figure>\n\n
\n \n
\n Phase<\/b><\/th>\n Service<\/b><\/th>\n Description<\/b><\/th>\n Deliverables<\/b><\/th>\n Timeline<\/b><\/th>\n <\/tr>\n <\/thead>\n \n \n Phase 1<\/td>\n Antigen Preparation<\/td>\n Design and production of peptide or recombinant antigen<\/td>\n Antigen material, design report<\/td>\n 1\u20133 weeks<\/td>\n <\/tr>\n \n Phase 2<\/td>\n Immunization & Library Generation<\/td>\n Animal immunization and immune response monitoring<\/td>\n Serum samples, titer data<\/td>\n 4\u20138 weeks<\/td>\n <\/tr>\n \n Phase 3<\/td>\n Screening & Clone Selection<\/td>\n Hybridoma screening or single B-cell selection<\/td>\n Candidate clones, screening data<\/td>\n 2\u20134 weeks<\/td>\n <\/tr>\n \n Phase 4<\/td>\n Expression & Production<\/td>\n Small-scale expression and scale-up in mammalian systems<\/td>\n Purified antibody (mg scale)<\/td>\n 2\u20133 weeks<\/td>\n <\/tr>\n \n Phase 5<\/td>\n Purification & QC<\/td>\n Affinity purification and analytical testing<\/td>\n QC report, purified antibody<\/td>\n 1\u20132 weeks<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n\n Typical total timeline:<\/b> ~8\u201316 weeks
Timelines may vary depending on antigen complexity, platform selection, and screening outcomes.<\/p>\n\nQuality & Validation<\/h2>\n
We focus on delivering antibodies that are experimentally useful and reproducible.<\/p>\n\n
Standard Quality Control<\/h3>\n
- \n
- Purity assessment (SDS-PAGE)<\/li>\n
- Binding validation (ELISA or equivalent)<\/li>\n <\/ul>\n\n
Optional Advanced Characterization<\/h3>\n
- \n
- Application-specific testing (e.g., WB, IHC, flow cytometry, if required)<\/li>\n
- Affinity measurement (SPR or BLI)<\/li>\n
- Epitope binning or mapping<\/li>\n
- Cross-reactivity assessment<\/li>\n <\/ul>\n\n
Validation strategies are tailored based on your intended application.<\/p>\n\n
Why Researchers Choose AbTriva<\/h2>\n
- \n
- Multi-platform capability<\/b>
Access to hybridoma, phage display, and single B-cell technologies in one workflow<\/li>\n- Scientist-led project design<\/b>
Feasibility assessments based on antigen properties and experimental goals<\/li>\n- Flexible service structure<\/b>
Full-service development or modular project support<\/li>\n- Transparent timelines and checkpoints<\/b>
Clear communication at each stage of the project<\/li>\n- Application-focused development<\/b>
Antibodies developed with downstream use in mind, not just production<\/li>\n <\/ul>\n\nWe do not assume universal success across all targets. Antibody development outcomes depend on factors such as antigen design, immunogenicity, and screening performance. Our team works to optimize conditions and provide realistic expectations from the outset.<\/p>\n\n
Start Your Project<\/h2>\n
Whether you are developing a new antibody for a specific assay or scaling up an existing clone, we can help design a workflow aligned with your research goals.<\/p>\n
- \n
- Request a quote based on your target and application<\/li>\n
- Consult with our scientific team to select the appropriate platform<\/li>\n
- Submit antigen sequences or project details for evaluation<\/li>\n <\/ul>\n\n
Typical response time: 1\u20132 business days<\/h4>\n
Contact us to discuss your monoclonal antibody development needs.<\/p>\n","protected":false},"excerpt":{"rendered":"
Monoclonal antibodies (mAbs) are highly specific immunoglobulins derived from a single B-cell clone. They are widely used in research and assay development due to their ability to recognize defined epitopes with high specificity. Common monoclonal antibody discovery platforms include: Hybridoma technology (classical in vivo approach) Phage display (in vitro library-based selection) Single B-cell technologies (FACS […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-132125","service","type-service","status-publish","hentry"],"acf":[],"yoast_head":"\n
Custom Monoclonal Antibody Production Services - AbTrivia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Custom Monoclonal Antibody Production Services - AbTrivia\" \/>\n<meta property=\"og:description\" content=\"Monoclonal antibodies (mAbs) are highly specific immunoglobulins derived from a single B-cell clone. They are widely used in research and assay development due to their ability to recognize defined epitopes with high specificity. Common monoclonal antibody discovery platforms include: Hybridoma technology (classical in vivo approach) Phage display (in vitro library-based selection) Single B-cell technologies (FACS […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/\" \/>\n<meta property=\"og:site_name\" content=\"AbTrivia\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T01:13:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/\",\"url\":\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/\",\"name\":\"Custom Monoclonal Antibody Production Services - AbTrivia\",\"isPartOf\":{\"@id\":\"https:\/\/abtriva.com\/cn\/#website\"},\"datePublished\":\"2026-06-26T01:12:55+00:00\",\"dateModified\":\"2026-06-26T01:13:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/#breadcrumb\"},\"inLanguage\":\"ko_KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.abtriva.com\/ko\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Services\",\"item\":\"https:\/\/www.abtriva.com\/ko\/service\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Custom Monoclonal Antibody Production Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/abtriva.com\/cn\/#website\",\"url\":\"https:\/\/abtriva.com\/cn\/\",\"name\":\"AbTrivia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/abtriva.com\/cn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ko_KR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Custom Monoclonal Antibody Production Services - AbTrivia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/","og_locale":"ko_KR","og_type":"article","og_title":"Custom Monoclonal Antibody Production Services - AbTrivia","og_description":"Monoclonal antibodies (mAbs) are highly specific immunoglobulins derived from a single B-cell clone. They are widely used in research and assay development due to their ability to recognize defined epitopes with high specificity. Common monoclonal antibody discovery platforms include: Hybridoma technology (classical in vivo approach) Phage display (in vitro library-based selection) Single B-cell technologies (FACS […]","og_url":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/","og_site_name":"AbTrivia","article_modified_time":"2026-06-26T01:13:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/","url":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/","name":"Custom Monoclonal Antibody Production Services - AbTrivia","isPartOf":{"@id":"https:\/\/abtriva.com\/cn\/#website"},"datePublished":"2026-06-26T01:12:55+00:00","dateModified":"2026-06-26T01:13:01+00:00","breadcrumb":{"@id":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/#breadcrumb"},"inLanguage":"ko_KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.abtriva.com\/ko\/service\/custom-monoclonal-antibody-production-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.abtriva.com\/ko\/"},{"@type":"ListItem","position":2,"name":"Services","item":"https:\/\/www.abtriva.com\/ko\/service\/"},{"@type":"ListItem","position":3,"name":"Custom Monoclonal Antibody Production Services"}]},{"@type":"WebSite","@id":"https:\/\/abtriva.com\/cn\/#website","url":"https:\/\/abtriva.com\/cn\/","name":"AbTrivia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/abtriva.com\/cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ko_KR"}]}},"_links":{"self":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/service\/132125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/service"}],"about":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/types\/service"}],"author":[{"embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/comments?post=132125"}],"version-history":[{"count":1,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/service\/132125\/revisions"}],"predecessor-version":[{"id":132126,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/service\/132125\/revisions\/132126"}],"wp:attachment":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/media?parent=132125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/categories?post=132125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/tags?post=132125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Scientist-led project design<\/b>
- Multi-platform capability<\/b>